AC2993 (synthetic exendin-4) added to existing metformin (Met) and/or sulfonylurea (SFU) treatment improved glycemic control in patients with type 2 …
A practical and efficient approach to database quality audit in clinical trials
A Bayesian approach to utilizing prior data in new drug development
A Novel Design for Decision Rules Based on Statistical Testing Strategies of Binary Endpoints in a Definitive Go/No-Go Single-Treatment Clinical Study
Statistical review
Cigarette Smoking Behavior in the United States (PDF)
Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systems
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes
Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets
Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis
Consistency of continual reassessment method under model misspecification
On Chiang’s explicit solutions for the Kolmogorov differential equations
On optimal B-robust influence functions in multidimensional parametric models
On optimal B-robust influence functions in semiparametric models
Robust Estimation for Semiparametric Exponential Mixture Models
Optimal robust estimates for semiparametric symmetric location models
Continual reassessment method: a likelihood approach
Application of boundary calculation methodologies to group sequential testing in general parametric models
Estimation of mean quality adjusted survival time
Two-sample continual reassessment method
Using a one-parameter model to sequentially estimate the root of a regression function
Design and analysis of dose escalation studies to mitigate dose-limiting adverse effects
Effectiveness of progressive dose‐escalation of exenatide (exendin‐4) in reducing dose‐limiting side effects in subjects with type 2 diabetes
Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year …
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes …
Properties of pramlintide and insulin upon mixing.
Copyright © 2025 Pharmapace - All Rights Reserved.
Powered by
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.